手机版 English 帮助中心
外文文献知网节
文献信息节点
基本信息 摘要 关键词 核心评价 相关文献
Journal | [J] 国际护理医学 Volume 4, Issue 5. 2022.
肌钙蛋白I与新冠肺炎患者死亡率的关系：荟萃分析研究
作者 : Hesthi Krisnawati, Yulia Dewi, Bhisma Murti
DOI: 10.12361/2661-4812-04-05-105355
全部来源
获取全文
摘要 / Abstract
背景：新冠肺炎是由严重急性呼吸综合征冠状病毒2型（新型冠状病毒）引起的一种新疾病。新冠肺炎 成为一种疫情，在将近两年的时间里导致400万人死亡。患有合并症和危险因素的新冠肺炎患者预后更差，其中之 一是心脏病。心脏病可通过肌钙蛋白I值检查。本研究旨在确定新冠肺炎患者肌钙蛋白I水平与死亡率之间的关系。 受试者和方法：这是一项系统性综述和荟萃分析，通过使用关键词：肌钙蛋白I、队列、死亡、心脏生物标志物、死 亡、冠状病毒、新冠肺炎死亡率和新冠肺炎，从Science Direct、Springer、谷歌学术和PubMed等数据库中搜索文章。 2019-2021年间发表的10篇认证文章被纳入荟萃分析。这项研究的对象是10，499名新冠肺炎患者。这项研究中的干 预是高肌钙蛋白I水平，而对照是正常的肌钙蛋白I水平。这项研究的结果是COVID-19患者的死亡率。使用Review Manager软件5.3版对新冠肺炎患者肌钙蛋白I水平和死亡率之间的关系进行数据处理。结果：对中国、西班牙、纽约 （美国）、法国、土耳其和费城（美国）的10篇主要研究文章的荟萃分析显示，高肌钙蛋白I水平与新冠肺炎患者死亡 风险增加相关（aOR=3.07；95%CI=1.68-5.61；p
关键词 / Keywords
肌钙蛋白I；心脏病；死亡率；新冠肺炎
Related articles / 相关文献
相似文献
作者发文
机构发文
关键词分析
相似文献（说明：与本文内容较接近的文献）
  • [1]Cetinkal G, Kocas BB, Ser OS, Kilci H, Keskin K,
  • Ozcan SN, Verdi Y, et al. (2020). Assessment of the modified
  • cha2ds2vasc risk score in predicting mortality in patients
  • hospitalized with COVID-19. Am. J. Cardiol. 1-7.
  • [2]Chen H, Li X, Marmar T, Xu Q, Tu J, Li T, Han J, et
  • al. (2021). Cardiac troponin i association with critical illness
  • and death risk in 726 seriously ill COVID-19 patients: a
  • retrospective cohort study. Int. j. med. sci. res. 18(6): 1474–
  • 1483.
  • [3]Chen LQ, Burdowski J, Marfatia R, Weber J, Gliganic
  • K, Diaz N, Ramjattan N, et al. (2020). Reduced cardiac
  • function is asso-ciated with cardiac injury and mortality risk
  • in hospitalized COVID-19 Patients. Clin. Cardiol. 43(12):
  • 1547–1554.
  • [4]Cordeanu EM, Duthil N, Severac F, Lambach H,
  • Tousch J, Jambert L, Mirea C, et al. (2020). Prognostic value of
  • troponin elevation in COVID-19 hospitalized patients. J Clin
  • Med. 9(12): 4078.
  • [5]Du R, Liang L, Yang C, Wang W, Cao T, Li M, Guo G,
  • et al. (2020). Predictors of mortality for patients with COVID￾19 pneumonia caused by SARS-CoV-2: a prospective cohort
  • study. Eur. Respir. J. 55:1-8.
  • [6]Guadiana LG, Morell RD, Rodríguez GO, Indiano
  • CM, María A, Padilla L, Miquel J, et al. (2021). Cardiac
  • troponin and COVID-19 severity: results from biocovid study.
  • Eur J Clin Invest. 1–12.
  • [7]Harmouch F, Shah K, Hippen JT, Kumar A, Goel
  • H (2021). Is it all in the heart? Myocardial injury as major
  • predictor of mortality among hospitalized COVID‐19 patients.
  • J. Med. Virol. 93: 973-982.
  • [8]Levani Y, Prastya AD, Mawaddatunnadila S, Wuhan
  • K, Huebei P (2019). Coronavirus Disease 2019 (COVID19): patogenesis, manifestasi klinis dan pilihan terapi. jurnal
  • kedokteran dan kesehatan. 17(1): 44-57.
  • [9]Majure DT, Gruberg L, Saba SG, Kvasnovsky C, Hirsch
  • JS, Jauhar R (2021). Usefulness of elevated troponin to predict
  • death in patients with COVID-19 and myocardial injury. Am J
  • Cardiovasc. 138: 100–106.
  • [10]Manocha KK, Kirzner J, Ying X, Yeo I, Peltzer B,
  • Ang B, Li HA, et al. (2020). Troponin and other biomarker
  • levels and outcomes among patients hospitalized with COVID19: derivation and validation of the ha2t2 COVID-19 mortality
  • risk score. J. Am. Heart Assoc. 1-12.
  • [11]Muhammad R, Ogunti R, Ahmed B, Munawar M,
  • Donaldson S, Sumon M, Kibreab A, et al. (2020). Clinical
  • characteristics and predictors of mortality in minority patients
  • hospitalized with COVID-19 infection. J. Racial and Ethn
  • Health Disparities.
  • [12]Murti B (2018). Prinsip dan Metode Riset
  • Epidemiologi. Karanganyar: Bintang Fajar Offset.
  • [13]Nie SF, Yu M, Xie T, Yang F, Wang HB, Wang
  • ZH, Li M, et al. (2020). Cardiac troponin i is an independent
  • predictor for mortality in hospitalized patients with COVID-19.
  • Circ. 142(6): 608–610.
  • [14]Ozyilmaz S, Alis EE, Ermis E, Allahverdiyev S, Ucar
  • H. (2020). Assessment of the re-lationship between mortality
  • and troponin I levels in hospitalized patients with the novel
  • coronavirus (COVID-19). Medicina. 56(693):1-12.
  • [15]Pane MDC (2021a). COVID-19. Retrieved from:
  • https://www.alodokter.com/COVID-19.
  • [16]Pane MDC (2021b). Virus Corona. Retrieved from:
  • https://www.alodokter.com-/virus-coro-na.
  • [17]Satria RMA, Tutupoho RP, Chalidyanto D. (2020).
  • Analisis faktor risiko kematian dengan penyakit komorbid
  • COVID-19. Jurnal Keperawatan Silampari. 4: 48–55.
  • [18]The Joanna Briggs Institute (2017). Critical Appraisal
  • tools for use in JBI Systematic Reviews Checklist for Cohort
  • Studies. http://joannabriggs.org/research/critical-appraisaltools.html.
  • [19]WHO (2021). WHO: Coronavirus (COVID-19)
  • Disease Dashboard. Retrieved from: https://covid19.who.int/.
  • [20]Woo SH, Rios-Diaz AJ, Kubey AA, Cheney-Peters
  • DR, Ackermann LL, Chalikon-da DM, Venkataraman CM, et
  • al. (2021). Development and validation of a web-based severe
  • COVID-19 risk prediction model. Am. J. Med. Sci., 1-28.
《中国学术期刊(光盘版)》电子杂志社有限公司 KDN平台基础技术由KBASE 11.0提供
© 2014-2018中国知网(CNKI) 京公网安备11010802020460号 经营性网站备案信息 互联网出版许可证 新出网证(京)字271号 京ICP证040431号